QS Investors, LLC - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 103 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$2,442,000
+115.2%
64,800
-2.8%
0.03%
+100.0%
Q4 2020$1,135,000
+415.9%
66,700
+42.5%
0.01%
+366.7%
Q3 2020$220,000
+1275.0%
46,800
+1772.0%
0.00%
Q2 2020$16,000
+166.7%
2,5000.0%0.00%
Q1 2020$6,000
+20.0%
2,500
+150.0%
0.00%
Q4 2019$5,000
+25.0%
1,0000.0%0.00%
Q3 2019$4,000
-99.5%
1,000
-94.3%
0.00%
-100.0%
Q4 2016$872,000
-69.7%
17,400
-68.2%
0.01%
-68.2%
Q3 2016$2,876,000
+79.3%
54,800
+41.2%
0.02%
+57.1%
Q2 2016$1,604,00038,8000.01%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Eventide Asset Management 1,085,200$44,873,0002.75%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 328,329$13,576,0000.94%
HAYS ADVISORY LLC 135,722$5,612,0000.87%
AWM Investment Company, Inc. 90,000$3,721,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 448,000$18,525,0000.73%
SPHERA FUNDS MANAGEMENT LTD. 60,000$2,481,0000.64%
RTW INVESTMENTS, LP 44,701$1,848,0000.63%
Telemetry Investments, L.L.C. 26,000$1,075,0000.58%
Spark Investment Management LLC 148,100$6,123,0000.57%
Perceptive Advisors 169,439$7,006,0000.49%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders